Punch & Associates Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Punch & Associates Investment Management's PFE Position: Q1 2024 in Review
Punch & Associates Investment Management sold out of Pfizer (PFE) in Q1 2024, closing a stake of 19,707 shares — an estimated $567K sold.
Punch & Associates Investment Management first reported a position in PFE in Q2 2018 and held it in 23 quarters. The position peaked at $1.16M in Q4 2021. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.
- Punch & Associates Investment Management reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
- Punch & Associates Investment Management sold 19,707 Pfizer shares in Q1 2024, an estimated $567K.
- Punch & Associates Investment Management first reported a position in Pfizer in Q2 2018 and held it in 23 quarters.
- Punch & Associates Investment Management's Pfizer position peaked at $1.16M in Q4 2021.
- 2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.
Based on Punch & Associates Investment Management's 13F filing for Q1 2024, filed 15 May 2024.